Robotic Needle Insertion During Computed Tomography Fluoroscopy-guided Biopsy: Prospective First-in-human Feasibility Trial
Overview
Authors
Affiliations
Introduction: This was a prospective, first-in-human trial to evaluate the feasibility and safety of insertion of biopsy introducer needles with our robot during CT fluoroscopy-guided biopsy in humans.
Materials And Methods: Eligible patients were adults with a lesion ≥ 10 mm in an extremity or the trunk requiring pathological diagnosis with CT fluoroscopy-guided biopsy. Patients in whom at-risk structures were located within 10 mm of the scheduled needle tract were excluded. Ten patients (4 females and 6 males; mean [range] age, 72 [52-87] years) with lesions (mean [range] maximum diameter, 28 [14-52] mm) in the kidney (n = 4), lung (n = 3), mediastinum (n = 1), adrenal gland (n = 1), and muscle (n = 1) were enrolled. The biopsy procedure involved robotic insertion of a biopsy introducer needle followed by manual acquisition of specimens using a biopsy needle. The patients were followed up for 14 days. Feasibility was defined as the distance of ≤ 10 mm between needle tip after insertion and the nearest lesion edge on the CT fluoroscopic images. The safety of robotic insertion was evaluated on the basis of machine-related troubles and adverse events according to the Clavien-Dindo classification.
Results: Robotic insertion of the introducer needle was feasible in all patients, enabling pathological diagnosis. There was no machine-related trouble. A total of 11 adverse events occurred in 8 patients, including 10 grade I events and 1 grade IIIa event.
Conclusion: Insertion of biopsy introducer needles with our robot was feasible at several locations in the human body.
Key Points: • Insertion of biopsy introducer needles with our robot during CT fluoroscopy-guided biopsy was feasible at several locations in the human body.
Innovations in Image-Guided Procedures: Unraveling Robot-Assisted Non-Hepatic Percutaneous Ablation.
Chlorogiannis D, Charalampopoulos G, Bale R, Odisio B, Wood B, Filippiadis D Semin Intervent Radiol. 2024; 41(2):113-120.
PMID: 38993597 PMC: 11236453. DOI: 10.1055/s-0044-1786724.
Micro-robotic percutaneous targeting of type II endoleaks in the angio-suite.
Widmann G, Deeg J, Frech A, Klocker J, Feuchtner G, Freund M Int J Comput Assist Radiol Surg. 2024; 19(8):1489-1494.
PMID: 38811484 PMC: 11329533. DOI: 10.1007/s11548-024-03195-y.
Trojak M, Stanuch M, Kurzyna M, Darocha S, Skalski A Cancers (Basel). 2024; 16(10).
PMID: 38791972 PMC: 11119171. DOI: 10.3390/cancers16101894.
Navigation and Robotics in Interventional Oncology: Current Status and Future Roadmap.
Charalampopoulos G, Bale R, Filippiadis D, Odisio B, Wood B, Solbiati L Diagnostics (Basel). 2024; 14(1).
PMID: 38201407 PMC: 10795729. DOI: 10.3390/diagnostics14010098.
Robotic systems in interventional oncology: a narrative review of the current status.
Matsui Y, Kamegawa T, Tomita K, Uka M, Umakoshi N, Kawabata T Int J Clin Oncol. 2023; 29(2):81-88.
PMID: 37115426 DOI: 10.1007/s10147-023-02344-8.